Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63 | 115 | 165 | 251 | 546 |
| Receivables | 7 | 7 | 7 | 39 | 11 |
| TOTAL | $72 | $137 | $192 | $315 | $557 |
| Non-Current Assets | |||||
| Investments And Advances | 1,569 | 1,845 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $1,569 | $1,845 | $0 | $0 | $2 |
| Total Assets | $1,641 | $1,982 | $192 | $315 | $559 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 12 |
| Accounts payable and accrued liabilities | 55 | 33 | 30 | 37 | 67 |
| Accrued Expenses | 129 | 131 | 145 | 134 | 212 |
| TOTAL | $183 | $164 | $175 | $171 | $291 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 805 | 775 | 745 | 737 | 707 |
| TOTAL | $805 | $775 | $745 | $737 | $707 |
| Total Liabilities | $988 | $938 | $920 | $908 | $997 |
| Shareholders' Equity | |||||
| Common Shares | 5,383 | 5,383 | 3,547 | 3,519 | 2,956 |
| Retained earnings | -5,618 | -5,227 | -5,163 | -5,335 | -4,353 |
| Other shareholders' equity | 791 | 791 | 791 | 1,224 | 958 |
| TOTAL | $653 | $1,044 | $-728 | $-592 | $-439 |
| Total Liabilities And Equity | $1,641 | $1,982 | $192 | $315 | $559 |